Nimbus Discovery, LLC, a biotechnology company discovering novel approaches
for previously inaccessible disease targets, and Monsanto Company MON, today
announced a collaboration to develop broad-spectrum fungicides, with new modes
of action, that help farmers control diseases and promote overall plant
health.
Fungal infections appear as rusts, leaf spots and blights on a range of
important food crops and are estimated to result in significant global crop
losses each year.
Under the terms of the agreement, a jointly-owned entity will be created that
has access to Nimbus' validated computational platform. Nimbus, with its
innovative research tools together with Monsanto's agricultural testing
capabilities will co-develop agricultural fungicides. Monsanto will have
access to applications within agriculture and Nimbus will retain rights for
all other applications. Financial terms were not disclosed.
“Working with Monsanto gives Nimbus a unique opportunity to showcase its
integrated computational chemistry and drug discovery strengths in the global
agricultural marketplace,” said Rosana Kapeller, M.D., Ph.D., Chief Scientific
Officer of Nimbus. “This partnership demonstrates the broad applicability of
the Nimbus platform and the ability of the Nimbus team to extract the greatest
value from our scientific assets.”
Monsanto's corporate venture group has an on-going strategic alliance with
Atlas Venture, founder of Nimbus Discovery, to explore co-investment
opportunities in early-stage life sciences technology companies. This
announcement is an investment supported by the alliance.
“Part of our commitment to bringing new technologies to agriculture is
identifying innovators we can work with to deliver solutions for our farmer
customers,” said Steve Padgette, Monsanto R&D investment strategy lead.
“Nimbus is breaking new ground with promising and novel work that has strong
potential to be applied in agriculture. We look forward to working with them
through this new collaboration, which will complement our own research
capabilities.”
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in